Analytical performance evaluation of Lumipulse® SARS-CoV-2 antigen assay in 392 asymptomatic patients.

Arnolfo PetruzzielloRocco SabatinoLivia Anna CatapaneCarmela De FalcoAntonella PettiElena TripaldelliGiovanna LoquercioAngela AnnecchiaricoAngela SalzilloEugenio CaradonnaPaolo Maggi

Published in: Journal of clinical laboratory analysis (2023)

Our data showed that Lumipulse® SARS-CoV-2 antigen assay might be an efficient tool in the identification and limitation of SARS-CoV-2 transmission in large asymptomatic populations.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
high throughput
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
big data
peritoneal dialysis
patient reported outcomes
mass spectrometry